Abstract:Huntington disease (HD) is an inherited neurodegenerative disorder affecting movement, mood and cognition, and striatal neurons show highest vulnerability to dysfunction and death. Calcium, a key messenger for transmitting external stimuli to the cell's nucleus, helps coordinate new protein expression that ultimately regulates neuronal health and connectivity in the brain. Here, we use a model system to explore the mechanisms of calcium signalling to the nucleus in striatal neurons, revealing critical roles for N‐methyl‐D‐aspartate receptors and ryanodine receptors, and demonstrating early impairment in this pathway in HD. Huntington's disease (HD) is a monogenic disorder with autosomal dominant inheritance. In HD patients, neurons in the striatum and cortex degenerate, leading to motor, psychiatric and cognitive disorders. Dysregulated synaptic function and calcium handling are common in many neurodegenerative diseases, including HD. N‐methyl‐D‐aspartate (NMDA) receptor function is enhanced in HD at extrasynaptic sites, altering the balance of calcium‐dependent neuronal survival versus death signalling pathways. Endoplasmic reticulum (ER) calcium handling is also abnormal in HD. The ER, which is continuous with the nuclear envelope, is purportedly involved in nuclear calcium signalling; based on this, we hypothesised that nuclear calcium signalling is altered in HD. We explored this hypothesis with calcium imaging techniques, including simultaneous epifluorescent imaging of cytosolic and nuclear calcium using jRCaMP1b and GCaMP3 sensors, respectively, in striatal spiny projection neurons in cortical–striatal co‐cultures from the YAC128 mouse model of HD. Our data show contributions from a variety of calcium channels to nuclear calcium signalling. NMDA receptors (NMDARs) play an essential role in initiating action potential‐dependent calcium signalling to the nucleus, and ryanodine receptors (RyR) contribute to both cytosolic and nuclear calcium signals. Unlike previous reports in glutamatergic hippocampal and cortical neurons, we found that in GABAergic striatal neurons, L‐type voltage‐gated calcium channels (CaV) contribute to cytosolic, but not nuclear calcium signalling. Calcium imaging also suggests impairments in nuclear calcium signalling in HD striatal neurons, where spontaneous action potential‐dependent calcium transients in the nucleus were smaller in YAC128 striatal neurons compared to those of wild‐type (WT). Our results elucidate mechanisms involved in action potential‐dependent nuclear calcium signalling in GABAergic striatal neurons, and have revealed a clear deficit in this signalling in HD.

Altered mitochondrial Ca2+ uptake in presynaptic terminals of cultured striatal and cortical neurons from the zQ175 knock-in mouse model of Huntington's disease

Dysregulation of Mitochondrial Calcium Signaling and Superoxide Flashes Cause Mitochondrial Genomic DNA Damage in Huntington Disease

Soluble N-terminal Fragment of Mutant Huntingtin Protein Impairs Mitochondrial Axonal Transport in Cultured Hippocampal Neurons.

Mechanisms of synapse‐to‐nucleus calcium signalling in striatal neurons and impairments in Huntington's disease

Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT Aggregation

Disruption of the mitochondrial network in a mouse model of Huntington's disease visualized by in-tissue multiscale 3D electron microscopy

Disruption of the mitochondrial network in a mouse model of Huntington's disease visualized by in tissue multiscale 3D electron microscopy

Mitochondrial HSF1 triggers mitochondrial dysfunction and neurodegeneration in Huntington's disease

N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking

Potassium channel dysfunction in neurons and astrocytes in Huntington's disease

Huntington's Disease Affects Mitochondrial Network Dynamics Predisposing to Pathogenic Mitochondrial DNA Mutations

Disposition of Proteins and Lipids in Synaptic Membrane Compartments is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum

Huntington disease affects mitochondrial network dynamics predisposing to pathogenic mtDNA mutations

Alterations in STriatal‐Enriched Protein Tyrosine Phosphatase Expression, Activation, and Downstream Signaling in Early and Late Stages of the YAC128 Huntington's Disease Mouse Model

Pathological Cell-Cell Interactions Are Necessary for Striatal Pathogenesis in a Conditional Mouse Model of Huntington's Disease.

Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's disease

Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington’s Disease

Enhanced Store-Operated Calcium Entry Leads To Striatal Synaptic Loss In A Huntington'S Disease Mouse Model

Dysregulation of protein SUMOylation networks in Huntington's disease R6/2 mouse striatum

Reduced Lysosomal Density in Neuronal Dendrites Mediates Deficits in Synaptic Plasticity in Huntington’s Disease

Impaired Ubiquitin–proteasome System Activity in the Synapses of Huntington's Disease Mice